Kota Arima

Kota Arima

Auto-generated profile, based on publicly available information

Kota Arima

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2017 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
YKYuki Kitano
Yuki Kitano
YYYo-Ichi Yamashita
Yo-Ichi Yamashita
KYKensuke Yamamura
Kensuke Yamamura
KAKota Arima
Kota Arima
TKTakayoshi Kaida
Takayoshi Kaida
HBHideo Baba
Hideo Baba
Background/Aim: As indicators of systemic inflammatory response, the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) predict prognoses for various cancers. This study investigated their prognostic significance in extrahepatic cholangiocarcinoma (ECC). Patients and Methods: We analyzed 120 patients who underwent surgery for ECC between 2000 and 2014. We calculated preoperative NLR and PLR and evaluated their correlations with patients' clinicopathological features and prognosis. Results: Although high NLR was not associated with worse recurrence-free survival (RFS) (hazard ratio (HR)=1.32, p=0.26), cancer-specific survival (CSS) (HR=1.35, p=0.31) and overall survival (OS) (HR=1.19, p=0.52), high PLR was significantly associated with worse RFS (HR=1.85, p=0.01), CSS (HR=2.38, p=0.002) and OS (HR=1.98, p=0.008). In multivariate analysis, high PLR (HR=1.89, p=0.02) and lymph node metastasis (HR=1.78, p=0.03) were independent prognostic factors for OS. A high PLR had more liver recurrences (p=0.04) and recurrences within 1 year (HR=2.38, p=0.02) than low PLR. Conclusion: High preoperative PLR was an independent predictor of poor prognosis for patients with ECC who underwent resections.

1 September 2016 in Pancreas
Verified
Journal Article
Closed access
DHDaisuke Hashimoto
Daisuke Hashimoto
KAKota Arima
Kota Arima
NYNaomi Yokoyama
Naomi Yokoyama
ACAkira Chikamoto
Akira Chikamoto
KTKatsunobu Taki
Katsunobu Taki
HBHideo Baba
Hideo Baba
Objectives Activating Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are the most common and frequent changes observed in pancreatic cancer. This study aimed to determine the frequency and extent of intratumoral and metastatic lymph node KRAS mutation heterogeneity of resected pancreatic ductal adenocarcinoma. Methods Tumor tissues macrodissected from tumor centers, invasion fronts (n = 97), and lymph nodes (n = 11) were subjected to DNA extraction and mutation analysis of KRAS codons 12 and 13 by pyrosequencing. Results Activating mutations in codon 12 of KRAS were detected in 90 (92.8%) tumor centers. No mutations were detected in KRAS codon 13 in any patient. After a comparison of tumor centers and invasion fronts, intratumoral heterogeneity of KRAS was observed only in 4 (4.1%) cases. Additional invasion front tumor analysis revealed the same mutation status consistent with each tumor center. No heterogeneity was observed between primary tumors and metastatic lymph nodes. Conclusions Intratumoral heterogeneity of the KRAS mutational status is rare in pancreatic ductal adenocarcinoma. In addition, no KRAS heterogeneity between primary tumors and metastatic lymph nodes was detected in this study. This finding is consistent with the hypothesis that oncogenic activation of KRAS is the first driver mutation in pancreatic cancer.


19 September 2013 in Surgery Today
Verified
Journal Article
Closed access
PDF file
KAKota Arima
Kota Arima
MWMasayuki Watanabe
Masayuki Watanabe
MIMasaaki Iwatsuki
Masaaki Iwatsuki
SISatoshi Ida
Satoshi Ida
TITakatsugu Ishimoto
Takatsugu Ishimoto
HBHideo Baba
Hideo Baba

1 November 2016
Verified
Journal Article
Closed access
DHDaisuke Hashimoto
Daisuke Hashimoto
KAKota Arima
Kota Arima
ACAkira Chikamoto
Akira Chikamoto
KTKatsunobu Taki
Katsunobu Taki
RIRisa Inoue
Risa Inoue
HBHideo Baba
Hideo Baba

10 April 2018 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
NUNaoki Umezaki
Naoki Umezaki
DHDaisuke Hashimoto
Daisuke Hashimoto
SNShigeki Nakagawa
Shigeki Nakagawa
TYTakanobu Yamao
Takanobu Yamao
MTMasayo Tsukamoto
Masayo Tsukamoto
HBHideo Baba
Hideo Baba
Gastrointestinal tract metastasis from pancreatic cancer is quite rare. We present the case of a 58-year-old male patient who underwent distal pancreatectomy for pancreatic body cancer 5 years prior. Four years after the initial operation, a 15-mm cystic submucosal tumor was found in the antrum of the stomach. Because the tumor had grown to 25 mm and the level of carcinoembryonic antigen in the cystic fluid derived by ultrasound-guided fine-needle aspiration biopsy was high, partial resection of the stomach was performed 5 years after the distal pancreatectomy. Pathological diagnosis was gastric metastasis of pancreatic cancer. The patient has been alive without recurrence for 13 months after the resection of the cystic tumor. We are not aware of any similar cases of cystic gastric metastasis from pancreatic cancer published in the English literature.